Search
for
Sort by
Research 91–120 of 1000+
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- 504 A single-center retrospective study evaluating the efficacy of intravenous methylprednisolone pulse therapy for 113 patients with alopecia areata
- Baricitinib for alopecia areata
- Efficacy and safety of janus kinase inhibitors in the treatment of alopecia areata in children
- The Efficacy of Baricitinib as a Treatment Option for Alopecia, In Terms of Promoting Hair Regrowth and Improving Patient Reported Outcomes
- Janus kinase inhibitors in dermatology: A systematic review
- Case Report of a Patient With Psoriasis Vulgaris, Psoriatic Arthritis and Alopecia Universalis Successfully Treated With Tofacitinib and Methotrexate
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- Janus Kinase (JAK) Inhibitors in Dermatology: An Update and Critical Review
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- Janus kinase inhibitor as a therapeutic option in alopecia areata. Case report
- EE325 Budget Impact of Baricitinib for Patients with Severe Alopecia Areata
- Inhibidor janus kinasa como opción terapéutica en alopecia areata. Reporte de caso
- Excellent response to tofacitinib treatment in a patient with alopecia universalis
- A Discrete Choice Experiment of Clinician Preferences Among Attributes of Approved Janus Kinase Inhibitors for Alopecia Areata
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
- The Economic Burden of Alopecia Areata: Evidence from a Survey in Norway and Sweden
- Hairy tongue associated with the use of baricitinib therapy for ophiasis pattern alopecia areata
- A Case of Tofacitinib for the Treatment of Resistant Vitiligo and Sustained Repigmentation After Discontinuation
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- Tofacitinib for the treatment of lichen planopilaris: A case series
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen
- Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair
- Alopecia areata flare patterns in children and young adults while on systemic tofacitinib
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata